Market Analysis — WILKES-BARRE GENERAL HOSPITAL
PA market | 5 hospitals | HHI: 4,894 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
5
Hospitals in Market
716
Total Beds
$1.2B
Market Revenue
Concentrated
HHI: 4,894
None
Moat Rating (4/10)
#2
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantagemoderate
Switching Costsmoderate
Market Share21.9%
Top 3 Concentration98.7%
Network Density0.70
Margin vs Market-13.6%
Bed Util vs Market-8.3%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The PA market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 4,894).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full PA market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| GEISINGER WYOMING VALLEY MED CTR | 309 | $783M | 65.5% | 43.2% |
| LEHIGH VALLEY HOSPITAL-HAZLETON | 134 | $136M | 11.4% | 18.7% |
| POST ACUTE MEDICAL AT NANTICOKE | 36 | $12M | 1.0% | 5.0% |
| FIRST HOSPITAL | 49 | $3M | 0.2% | 6.8% |
Regional Payer Mix
■ Medicare 38%■ Medicaid 8%■ Commercial 54%